Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

Sanofi reception

Sanofi and Amgen poised for cholesterol drug sales

Praluent to be assessed by FDA advisory committee later this week

- PMLiVE

Takeda files block on generic diet pill launch

Contrave is succumbing to patent attacks just months after being approved

Shire Basingstoke

Shire rumoured to be pursuing Actelion

Allegedly made a £12.4bn takeover bid for the Swiss biopharma

Redirecting your patient strategy

Pharma’s efforts to update its approach to patients often start at the top

- PMLiVE

Novo brings Xultophy to third European market

Launches diabetes combination of Tresiba-Victoza in the UK

- PMLiVE

FDA panel backs Sprout Pharma’s ‘female Viagra’

Could be approved for HSDD in pre-menopausal women

EU flag

Pharma says EU R&D budget cut ‘misguided’

EU lobby group criticises science funding cuts

Gilead Sciences

Humira remains top pharma product, but Sovaldi closes in

AbbVie’s blockbuster may be bumped to second place this year

- PMLiVE

Ardelyx buys back drug from AZ to ‘accelerate development’

The two firms have been working on the NHE3 inhibitor tenapanor since 2012

Boehringer Ingelheim headquarters

NICE U-Turn on Boehringer oncology drug

England’s drug price watchdog now recommends Vargatef for lung cancer after price cut

- PMLiVE

Sanofi rare disease drug a breakthrough, says FDA

Regulator awarded the status to olipudase alfa for metabolic disorder

Recipharm appoints chief strategy officer

Jean-François Hilaire will take up the role with immediate effect

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links